NEWFlashcards for any set of questions, quick-reference tables for breast, lung and prostate, and a month of access for every colleague you refer. See what changed

Haematology: DLBCL: consolidation radiotherapy for bulky disease (UNFOLDER)

Free question published 14 November 2026

HaematologyDLBCL: consolidation radiotherapy for bulky disease (UNFOLDER)

A 47-year-old man with stage II diffuse large B-cell lymphoma has a bulky mediastinal mass measuring 9 cm at diagnosis. He completes six cycles of R-CHOP-21 and his end-of-treatment PET-CT shows a complete metabolic response. His treatment follows the UNFOLDER trial design. Based on UNFOLDER, what does omitting consolidation radiotherapy to the original bulk do to his outcome?

  1. AIt mandates two further cycles of R-CHOP instead
  2. BIt is non-inferior, therefore radiotherapy can always be safely and routinely omitted after R-CHOP for bulky disease
  3. CIt significantly worsens event-free survival, which led to early closure of the no-radiotherapy arms
  4. DIt significantly improves overall survival by avoiding radiotherapy toxicity
  5. EIt has no measurable effect because PET complete response abolishes any benefit of radiotherapy

Why C is correct

In the UNFOLDER trial of aggressive B-cell lymphoma with bulky (7.5 cm or greater) or extralymphatic disease, a planned interim analysis found significantly better event-free survival in the radiotherapy arm, leading to predefined closure of the observation (no-radiotherapy) arms; 3-year EFS was 84% with radiotherapy versus 68% without. Consolidation radiotherapy to bulk after R-CHOP improved event-free survival.

And why the others are not

  • AIncorrect: UNFOLDER compared radiotherapy with observation, not additional R-CHOP cycles.
  • BIncorrect: UNFOLDER did not show non-inferiority of omission; the arms omitting radiotherapy were stopped for excess failures.
  • DIncorrect: omitting radiotherapy did not improve overall survival; it worsened event-free survival.
  • EIncorrect: in this trial radiotherapy to bulk still improved event-free survival, so the effect was not abolished.

Source UNFOLDER - consolidation radiotherapy to bulky disease in aggressive B-cell lymphoma — Held G, Thurner L, et al. Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study (DSHNHL/GLA). Hemasphere. 2023;7(7):e904.

Sitting in February? Follow the twenty-week plan.

2,500+ cited questions like this one are waiting in the vault.

See plans and pricing